In this episode of The Brainstorm, Sam Korus, Brett Winton, Nick Grous, and Frank Downing dive into the competitive landscape of AI, exploring why Google is outpacing its rivals with the release of Gemini 3. They discuss the implications of this technological leap, the transformative potential of Nano Banana Pro, and what it means for the future of AI. If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Wolf.financial, and sponsored by Public. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.Key Points From This Episode:Google's Gemini 3 is setting new benchmarks in AI, challenging the dominance of OpenAI's models.The introduction of Nano Banana Pro marks a significant advancement in AI's ability to process and present information visually.Google's strategic integration of AI across its services is enhancing user personalization and memory capabilities.The competitive dynamics in AI are shifting, with Google leveraging its full-stack capabilities to gain an edge over competitors.To learn more about WOLF: https://wolf.financialTo learn more about Public: https://public.com/
--------
45:03
--------
45:03
What’s Going On With AI Stocks? | The Brainstorm EP 110
In this episode of The Brainstorm, Sam Korus, Brett Winton, and Nick Grous dive into the current state of the market, discussing the recent downturn and its impact on major players like Bitcoin and Nvidia. They explore the narrative around AI as a potential bubble, the implications of major investors selling off their stakes, and the broader economic factors at play. The conversation also touches on the dynamics of AI monetization, the competitive landscape among tech giants, and the future of reusable rockets in the space industry.If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Wolf.financial, and sponsored by Public. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.Key Points From This Episode:The episode opens with a discussion on the recent market downturn and its impact on major tech stocks.The hosts explore the narrative surrounding AI as a potential bubble and its implications for the tech industry.Key economic factors, including government actions and investor behavior, are analyzed for their influence on market trends.The conversation delves into the strategies and challenges of monetizing AI technologies.The episode also touches on advancements in space technology, particularly the development of reusable rockets.To learn more about WOLF: https://wolf.financialTo learn more about Public: https://public.com/
--------
40:08
--------
40:08
Texting While ‘Driving’ In A Tesla Is… Allowed? | The Brainstorm EP 109
In this episode of The Brainstorm, Nick Grous, Tasha Keeney, and Brett Winton dive into the latest Tesla shareholder meeting, discussing Tesla's ambitious plans to build their own chip fab and the implications for the future of autonomous driving. They also explore Robinhood's strategic moves in the financial market and the potential of space-based data centers. If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.Key Points From This Episode:Tesla plans to build its own chip fab to ensure a steady supply for its vehicles and robotics, aiming to overcome manufacturing limitations.The discussion highlights Tesla's move towards full autonomy, with potential updates allowing texting while driving in the near future.Robinhood's strategy to attract Tesla shareholders with a 2% uncapped match is analyzed as a bold customer acquisition move.The feasibility and future of space-based data centers are explored, considering the challenges and opportunities in this emerging field.For more updates on Public.com:Website: https://public.com/YouTube: @publicinvestX: https://twitter.com/public
--------
36:14
--------
36:14
Curing Hair Loss With Sean McClain
In this episode, ARK’s Cathie Wood and Brett Winton sit down with Sean McClain, Founder and CEO of AbSci, to explore how generative AI is reshaping drug discovery, development timelines, and clinical costs. Sean walks through real-world examples of AI-designed antibodies—such as AbSci’s breakthrough HIV antibody and a regenerative treatment for hair loss—and explains how these platforms are helping unlock previously “undruggable” biology.They discuss AbSci’s Phase 2-ready hair growth antibody (BS201), the company’s partnerships with Caltech and AMD, and why the FDA’s evolving embrace of AI could accelerate the end of animal testing. The conversation closes with a forward-looking discussion on the role of regenerative medicine in longevity—and why AI drug discovery might just pull biotech out of its multi-year bear market.Key Points From This Episode:(00:00:00) How AbSci uses generative AI to design antibodies from scratch(00:02:42) HIV, ion channels, and the promise of targeting "undruggable" biology(00:06:28) AbSci’s BS201 drug for hair regrowth: mechanism, speed, and cost advantages(00:13:20) Clinical timeline: From concept to Phase 2 readout in 3.5 years(00:15:34) Bringing costs down: $100–150M vs. the industry average of $2.4B(00:17:36) Why AI enables “keys designed for specific locks” in drug targeting(00:22:58) What AbSci’s models are trained on—and how prompts work in drug inference(00:25:32) The future of clinical testing: AI replacing animal models(00:36:43) Sarcopenia, strength loss, and regenerative approaches to aging(00:48:10) BS201 as a long-acting pulse therapy—and how it compares to transplants
--------
54:18
--------
54:18
OpenAI's $1 Trillion Ambition | The Brainstorm EP 108
In this episode of The Brainstorm, hosts Nick Grous, Brett Winton, and guests Frank Downing and Jozef Soja dive into OpenAI's ambitious restructuring plan and its implications for a potential $1 trillion IPO. They explore the intricacies of OpenAI's partnership with Microsoft, the challenges of defining artificial general intelligence (AGI), and the strategic moves shaping the future of AI.If you know ARK, then you probably know about our long-term research projections, like estimating where we will be 5-10 years from now! But just because we are long-term investors, doesn’t mean we don’t have strong views and opinions on breaking news. In fact, we discuss and debate this every day. So now we’re sharing some of these internal discussions with you in our new video series, “The Brainstorm”, a co-production from ARK and Public.com. Tune in every week as we react to the latest in innovation. Here and there we’ll be joined by special guests, but ultimately this is our chance to join the conversation and share ARK’s quick takes on what’s going on in tech today.Key Points From This Episode:OpenAI has restructured as a public benefit corporation, with Microsoft holding a 27% stake. The restructuring includes a clause for declaring AGI, requiring independent verification.The company projects significant revenue growth, aiming for a $100 billion run rate by 2027. OpenAI's valuation could compress as it approaches a trillion-dollar IPO.OpenAI's potential IPO is driven by the need for increased compute and capital.The AI market is expected to see multiple large players, not just a single winner.Amazon's chatbot, Rufus, demonstrates successful consumer AI monetization.For more updates on Public.com:Website: https://public.com/YouTube: @publicinvestX: https://twitter.com/public
The FYI - For Your Innovation Podcast offers an intellectual discussion on recent developments across disruptive innovation—driven by research, news, controversies, companies, and technological breakthroughs. Hosted by ARK Invest, ARK and guests provide a unique perspective on how to best understand disruptive innovation.
Brasil